Aspiriant Holdings S3’s AbbVie ABBV Stock Holding History

Aspiriant Holdings S3’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,743	Closed	-$251K	–	105
2015 Q2	$251K	Sell	3,743 -200	-5%	-$13.1K	0.1%	101
2015 Q1	$231K	Sell	3,943 -380	-9%	-$23K	0.09%	103
2014 Q4	$283K	Buy	4,323 +573	+15%	+$36.1K	0.12%	102
2014 Q3	$217K	Sell	3,750 -280	-7%	-$15.5K	0.09%	107
2014 Q2	$227K	Buy	4,030 +5	+0.1%	+$262	0.09%	112
2014 Q1	$207K	Sell	4,025 -200	-5%	-$10.1K	0.09%	107
2013 Q4	$223K	Sell	4,225 -1,531	-27%	-$75.2K	0.09%	100
2013 Q3	$257K	Sell	5,756 -51,734	-90%	-$2.29M	0.11%	95
2013 Q2	$2.38M	Buy	+57,490	New	+$2.51M	1.07%	44

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Aspiriant Holdings S3's ABBV Position: Q3 2015 in Review

Aspiriant Holdings S3 sold out of AbbVie (ABBV) in Q3 2015, closing a stake of 3,743 shares — an estimated $251K sold.

Aspiriant Holdings S3 first reported a position in ABBV in Q2 2013 and held it in 9 quarters. The position peaked at $2.38M in Q2 2013. 1,604 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

Aspiriant Holdings S3 reported no remaining AbbVie position as of Q3 2015 after selling out during the quarter.
Aspiriant Holdings S3 sold 3,743 AbbVie shares in Q3 2015, an estimated $251K.
Aspiriant Holdings S3 first reported a position in AbbVie in Q2 2013 and held it in 9 quarters.
Aspiriant Holdings S3's AbbVie position peaked at $2.38M in Q2 2013.
1,604 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Aspiriant Holdings S3's 13F filing for Q3 2015, filed 23 Oct 2015.